PASITHEA THERAPEUTICS CORP. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PASITHEA THERAPEUTICS CORP. (KTTA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.98 million shares for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-08-11
- PASITHEA THERAPEUTICS CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 2.18M shares, a 263.33% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 600.00K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|---|
| 2023-06-30 | 1.98M shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 2.18M shares 10-Q · filed 2023-05-12 | |
| 2022-06-30 | 1.00M shares 10-Q · filed 2023-08-11 | |
| 2022-03-31 | 600.00K shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |